Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release

Journal of Biological Chemistry

Volumn 288, Issue 38, 2013, Pages 27534-27544

  Rickhag, Mattias ^a   Owens, William A ^b   Winkler, Marie Therese ^c   Strandfelt, Kristine Nørgaard ^a   Rathje, Mette ^a   Sørensen, Gunnar ^a   Andresen, Bjørn ^a   Madsen, Kenneth L ^a   Jørgensen, Trine Nygaard ^a   Wörtwein, Gitta ^a   Woldbye, David P D ^a   Sitte, Harald ^c   Daws, Lynette C ^b   Gether, Ulrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1-METHYL-4-PHENYLPYRIDINIUM; CO-IMMUNOPRECIPITATION EXPERIMENTS; DOPAMINE TRANSPORTERS; HETEROLOGOUS CELLS; MEMBRANE TRANSDUCTION; MEMBRANE-PERMEABLE; PROTEIN-PROTEIN INTERACTIONS; SYSTEMIC ADMINISTRATION;

AMINES; CELL MEMBRANES; CYTOLOGY; NEUROPHYSIOLOGY;

PEPTIDES;

1 METHYL 4 PHENYLPYRIDINIUM; AMPHETAMINE; BINDING PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IIALPHA; CALCIUM ION; DISCS LARGE PROTEIN; DOPAMINE; DOPAMINE TRANSPORTER; PDZ PROTEIN; PEPTIDE; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN ZO1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; ENZYME ACTIVITY; ENZYME BINDING; EVOKED RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERACTIVITY; IN VIVO STUDY; LOCOMOTION; MALE; MEMBRANE FUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADDICTION; DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORT; PROTEIN KINASES; PROTEIN-PROTEIN INTERACTIONS; SCAFFOLD PROTEINS;

AMPHETAMINE; ANIMALS; BENZYLAMINES; CELL-PENETRATING PEPTIDES; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; MICE; MOTOR ACTIVITY; PDZ DOMAINS; PROTEIN KINASE C-ALPHA; PROTEIN KINASE INHIBITORS; SULFONAMIDES;

EID: 84884581902     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.441295     Document Type: Article

References (50)

1. Gainetdinov, R. R., and Caron, M. G. (2003) Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43, 261-284
2. Torres, G. E., and Amara, S. G. (2007) Glutamate and monoamine transporters: new visions of form and function. Curr. Opin. Neurobiol. 17, 304-312
3. Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., and Gether, U. (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev. 63, 585-640
4. Sager, J. J., and Torres, G. E. (2011) Proteins interacting with monoamine transporters: current state and future challenges. Biochemistry 50, 7295-7310
5. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., and Caron, M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612
6. Beuming, T., Kniazeff, J., Bergmann, M. L., Shi, L., Gracia, L., Raniszewska, K., Newman, A. H., Javitch, J. A., Weinstein, H., Gether, U., and Loland, C. J. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat. Neurosci. 11, 780-789
7. Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., and Caron, M. G. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. U. S. A. 95, 4029-4034
8. Sitte, H. H., Huck, S., Reither, H., Boehm, S., Singer, E. A., and Pifl, C. (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71, 1289-1297
9. Sulzer, D., Sonders, M. S., Poulsen, N. W., and Galli, A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406-433
10. Daniels, G. M., and Amara, S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 35794-35801
11. Kahlig, K. M., Javitch, J. A., and Galli, A. (2004) Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J. Biol. Chem. 279, 8966-8975
12. Saunders, C., Ferrer, J. V., Shi, L., Chen, J., Merrill, G., Lamb, M. E., Leeb-Lundberg, L. M., Carvelli, L., Javitch, J. A., and Galli, A. (2000) Amphetamineinduced loss of human dopamine transporter activity: an internalizationdependent and cocaine-sensitive mechanism. Proc. Natl. Acad. Sci. U. S. A. 97, 6850-6855
13. +/calmodulin-dependent kinase II-dependent mechanism. Mol. Pharmacol. 71, 835-842
14. Eriksen, J., Jørgensen, T. N., and Gether, U. (2010) Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J. Neurochem. 113, 27-41
15. Torres, G. E. (2006) The dopamine transporter proteome. J. Neurochem. 97, 3-10
16. Torres, G. E., Yao, W. D., Mohn, A. R., Quan, H., Kim, K. M., Levey, A. I., Staudinger, J., and Caron, M. G. (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domaincontaining protein PICK1. Neuron 30, 121-134
17. Fog, J. U., Khoshbouei, H., Holy, M., Owens, W. A., Vaegter, C. B., Sen, N., Nikandrova, Y., Bowton, E., McMahon, D. G., Colbran, R. J., Daws, L. C., Sitte, H. H., Javitch, J. A., Galli, A., and Gether, U. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417-429
18. Bjerggaard, C., Fog, J. U., Hastrup, H., Madsen, K., Loland, C. J., Javitch, J. A., and Gether, U. (2004) Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J. Neurosci. 24, 7024-7036
19. Rickhag, M., Hansen, F. H., Srénsen, G., Strandfelt, K. N., Andresen, B., Gotfryd, K., Madsen, K. L., Vestergaard-Klewe, I., Ammendrup-Johnsen, I., Eriksen, J., Newman, A. H., Füchtbauer, E. M., Gomeza, J., Woldbye, D. P., Wörtwein, G., and Gether, U. (2013) A C-terminal PDZ domainbinding sequence is required for striatal distribution of the dopamine transporter. Nat. Commun. 4, 1580
20. Foster, J. D., Pananusorn, B., and Vaughan, R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 25178-25186
21. Vaughan, R. A., Huff, R. A., Uhl, G. R., and Kuhar, M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 15541-15546
22. Khoshbouei, H., Sen, N., Guptaroy, B., Johnson, L., Lund, D., Gnegy, M. E., Galli, A., and Javitch, J. A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78
23. +-and calmodulin-dependent phosphorylation and synaptic vesicles. J. Neurosci. 19, 3801-3808
24. Pierce, R. C., and Kalivas, P. W. (1997) Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17, 3254-3261
25. + regulates amphetamineinduced dopamine efflux and currents mediated by the human dopamine transporter. Mol. Pharmacol. 66, 137-143
26. +CaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J. Biol. Chem. 287, 29627-29635
27. Scholze, P., Nørregaard, L., Singer, E. A., Freissmuth, M., Gether, U., and Sitte, H. H. (2002) The role of zinc ions in reverse transport mediated by monoamine transporters. J. Biol. Chem. 277, 21505-21513
28. Owens, W. A., Sevak, R. J., Galici, R., Chang, X., Javors, M. A., Galli, A., France, C. P., and Daws, L. C. (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J. Neurochem. 94, 1402-1410
29. Williams, J. M., Owens, W. A., Turner, G. H., Saunders, C., Dipace, C., Blakely, R. D., France, C. P., Gore, J. C., Daws, L. C., Avison, M. J., and Galli, A. (2007) Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol. 5, e274
30. Callaghan, P. D., Irvine, R. J., and Daws, L. C. (2005) Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3, 4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem. Int. 47, 350-361
31. Clausing, P., Gough, B., Holson, R. R., Slikker, W., Jr., and Bowyer, J. F. (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra, and plasma after dosage that produces either behavioral or neurotoxic effects. J. Pharmacol. Exp. Ther. 274, 614-621
32. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572
33. Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y. T., Salter, M. W., and Tymianski, M. (2002) Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298, 846-850
34. Bertaso, F., Zhang, C., Scheschonka, A., De Bock, F., Fontanaud, P., Marin, P., Huganir, R. L., Betz, H., Bockaert, J., Fagni, L., and Lerner-Natoli, M. (2008) PICK1 uncoupling from mGluR7a causes absence-like seizures. Nat. Neurosci. 11, 940-948
35. Brebner, K., Wong, T. P., Liu, L., Liu, Y., Campsall, P., Gray, S., Phelps, L., Phillips, A. G., and Wang, Y. T. (2005) Nucleus accumbens long-term depression and the expression of behavioral sensitization. Science 310, 1340-1343
36. Bach, A., Clausen, B. H., Møller, M., Vestergaard, B., Chi, C. N., Round, A., Sørensen, P. L., Nissen, K. B., Kastrup, J. S., Gajhede, M., Jemth, P., Kristensen, A. S., Lundström, P., Lambertsen, K. L., and Strømgaard, K. (2012) A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage. Proc. Natl. Acad. Sci. U. S. A. 109, 3317-3322
37. Pizzo, A. B., Karam, C. S., Zhang, Y., Yano, H., Freyberg, R. J., Karam, D. S., Freyberg, Z., Yamamoto, A., McCabe, B. D., and Javitch, J. A. (2013) The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. Mol. Psychiatry 18, 824-833
38. Sakrikar, D., Mazei-Robison, M. S., Mergy, M. A., Richtand, N. W., Han, Q., Hamilton, P. J., Bowton, E., Galli, A., Veenstra-Vanderweele, J., Gill, M., and Blakely, R. D. (2012) Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. J. Neurosci. 32, 5385-5397
39. Daws, L. C., Montañez, S., Owens, W. A., Gould, G. G., Frazer, A., Toney, G. M., and Gerhardt, G. A. (2005) Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. J. Neurosci. Methods 143, 49-62
40. + channel 1) and ASIC (acid-sensing ion channel). Biochem. J. 361, 443-450
41. Xia, J., Chung, H. J., Wihler, C., Huganir, R. L., and Linden, D. J. (2000) Cerebellar long-term depression requires PKC-regulated interactions between GluR2/3 and PDZ domain-containing proteins. Neuron 28, 499-510
42. Cowell, R. M., Kantor, L., Hewlett, G. H., Frey, K. A., and Gnegy, M. E. (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur. J. Pharmacol. 389, 59-65
43. Johnson, L. A., Guptaroy, B., Lund, D., Shamban, S., and Gnegy, M. E. (2005) Regulation of amphetamine-stimulated dopamine efflux by protein kinase Cβ. J. Biol. Chem. 280, 10914-10919
44. Cervinski, M. A., Foster, J. D., and Vaughan, R. A. (2005) Psychoactive substrates stimulate dopamine transporter phosphorylation and downregulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J. Biol. Chem. 280, 40442-40449
45. Binda, F., Dipace, C., Bowton, E., Robertson, S. D., Lute, B. J., Fog, J. U., Zhang, M., Sen, N., Colbran, R. J., Gnegy, M. E., Gether, U., Javitch, J. A., Erreger, K., and Galli, A. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 74, 1101-1108
46. Bowton, E., Saunders, C., Erreger, K., Sakrikar, D., Matthies, H. J., Sen, N., Jessen, T., Colbran, R. J., Caron, M. G., Javitch, J. A., Blakely, R. D., and Galli, A. (2010) Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attentiondeficit hyperactivity disorder. J. Neurosci. 30, 6048-6057
47. Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R. D., McMahon, D. G., Javitch, J. A., and Galli, A. (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Natl. Acad. Sci. U. S. A. 102, 3495-3500
48. Sucic, S., Dallinger, S., Zdrazil, B., Weissensteiner, R., Jørgensen, T. N., Holy, M., Kudlacek, O., Seidel, S., Cha, J. H., Gether, U., Newman, A. H., Ecker, G. F., Freissmuth, M., and Sitte, H. H. (2010) The N terminus of monoamine transporters is a lever required for the action of amphetamines. J. Biol. Chem. 285, 10924-10938
49. Navaroli, D. M., Stevens, Z. H., Uzelac, Z., Gabriel, L., King, M. J., Lifshitz, L. M., Sitte, H. H., and Melikian, H. E. (2011) The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. J. Neurosci. 31, 13758-13770
50. Franklin, K. B. J., and Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates, 2nd Ed., Academic Press, San Diego